Free Trial
OTCMKTS:PKPH

Peak Pharmaceuticals (PKPH) Stock Price, News & Analysis

Peak Pharmaceuticals logo
$1.02 -0.07 (-6.65%)
As of 06/27/2025

About Peak Pharmaceuticals Stock (OTCMKTS:PKPH)

Key Stats

Today's Range
$1.02
$1.02
50-Day Range
$0.81
$4.00
52-Week Range
$0.52
$9.12
Volume
100 shs
Average Volume
9,053 shs
Market Capitalization
$398.86 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Receive PKPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Peak Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PKPH Stock News Headlines

Akari Therapeutics Merges with Peak Bio for Growth
New Rule Hits in July — The Smart Money Already Moved
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Daytime and early peak commissioning
See More Headlines

PKPH Stock Analysis - Frequently Asked Questions

Peak Pharmaceuticals' stock was trading at $1.07 at the beginning of 2025. Since then, PKPH shares have decreased by 4.9% and is now trading at $1.0175.
View the best growth stocks for 2025 here
.

Shares of PKPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Peak Pharmaceuticals investors own include Ginkgo Bioworks (DNA), Jazz Pharmaceuticals (JAZZ), Medical Marijuana (MJNA), Altria Group (MO), OPKO Health (OPK), Growlife (PHOT) and RTX (RTX).

Company Calendar

Today
6/28/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Cannabis
Current Symbol
OTCMKTS:PKPH
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$160 thousand
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
320,000
Market Cap
$392 thousand
Optionable
Not Optionable
Beta
0.54
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:PKPH) was last updated on 6/28/2025 by MarketBeat.com Staff
From Our Partners